LM_ID
|
Common Name
|
Systematic Name
|
Main class
|
Sub class
|
Mass
|
Formula
|
LMFA03110194
|
5-epi-12-E2t-IsoP
|
4-((1R,2R,3R)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110066
|
5-epi-5-D2c-IsoP
|
5R,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110069
|
5-epi-5-D2t-IsoP
|
5R,9S-dihydroxy-11-oxo-6E,14Z-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110171
|
5-epi-5-E2c-IsoP
|
(R,E)-5-hydroxy-7-((1R,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110172
|
5-epi-5-E2t-IsoP
|
(R,E)-5-hydroxy-7-((1S,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110223
|
8,11-diepi-8-D2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110224
|
8,11-diepi-8-D2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2R,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110216
|
8,11-diepi-8-E2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110215
|
8,11-diepi-8-E2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110131
|
8,15-diepi-15-D2c-IsoP
|
11-oxo-9S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110175
|
8,5-diepi-5-E2c-IsoP
|
(R,E)-5-hydroxy-7-((1S,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110176
|
8,5-diepi-5-E2t-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110051
|
8-D2c-IsoP
|
8S,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110057
|
8-D2t-IsoP
|
8S,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110214
|
8-E2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110213
|
8-E2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110132
|
8-epi-15-D2c-IsoP
|
11-oxo-9S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110127
|
8-epi-15-E2c-IsoP
|
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110229
|
8-epi-5-D2c-IsoP
|
(S,E)-5-hydroxy-7-((1S,2S,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110230
|
8-epi-5-D2t-IsoP
|
(S,E)-5-hydroxy-7-((1R,2R,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110177
|
8-epi-5-E2c-IsoP
|
(S,E)-5-hydroxy-7-((1S,2S,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110178
|
8-epi-5-E2t-IsoP
|
(S,E)-5-hydroxy-7-((1R,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110052
|
8-epi-8-D2c-IsoP
|
8R,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11R,15S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110056
|
8-epi-8-D2t-IsoP
|
8R,12S-dihydroxy-14-oxo-5Z,9E-prostadienoic acid-cyclo[11S,15R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110218
|
8-epi-8-E2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2S,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110217
|
8-epi-8-E2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110005
|
8-iso-15-keto-PGF2alpha
|
9S,11R-dihydroxy-15-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110003
|
8-iso-PGE2
|
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110007
|
8-iso-PGF3alpha
|
9S,11R,15S-trihydroxy-5Z,13E,17Z-prostatrienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110225
|
ent-11-epi-8-D2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2R,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110226
|
ent-11-epi-8-D2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2S,5R)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110204
|
ent-11-epi-8-E2c-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1R,2R,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110203
|
ent-11-epi-8-E2t-IsoP
|
(R,5Z,9E)-8-hydroxy-10-((1S,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110078
|
ent-12-D2c-IsoP
|
6R,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110083
|
ent-12-D2t-IsoP
|
6R,12R-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110197
|
ent-12-E2c-IsoP
|
4-((1S,2R,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110198
|
ent-12-E2t-IsoP
|
4-((1R,2S,3S)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110081
|
ent-12-epi-12-D2c-IsoP
|
6R,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5S,9R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110082
|
ent-12-epi-12-D2t-IsoP
|
6R,12S-dihydroxy-8-oxo-10E,14Z-prostadienoic acid-cyclo[5R,9S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110195
|
ent-12-epi-12-E2c-IsoP
|
4-((1S,2R,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110196
|
ent-12-epi-12-E2t-IsoP
|
4-((1R,2S,3S)-3-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110092
|
ent-15-D2c-IsoP
|
9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110097
|
ent-15-D2t-IsoP
|
9R,15R-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110117
|
ent-15-E2c-IsoP
|
9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110116
|
ent-15-E2t-IsoP
|
9-oxo-11S,15R-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110095
|
ent-15-epi-15-D2c-IsoP
|
9R,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110096
|
ent-15-epi-15-D2t-IsoP
|
9R,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110121
|
ent-15-epi-15-E2c-IsoP
|
9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110120
|
ent-15-epi-15-E2t-IsoP
|
9-oxo-11S,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8R,12S]
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|
LMFA03110243
|
ent-5,12-diepi-12-D2c-IsoP
|
4-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-3-oxocyclopentyl)butanoic acid
|
Eicosanoids [FA03]
|
Isoprostanes [FA0311]
|
352.22
|
C20H32O5
|